Inhibition of dendritic cell maturation and function is independent of heme oxygenase 1 but requires the activation of STAT3

Journal of Immunology

Volumn 180, Issue 12, 2008, Pages 7919-7930

  Mashreghi, Mir Farzin ^a   Klemz, Roman ^a   Knosalla, Isabel Schmitt ^a   Gerstmayer, Bernhard ^b   Janssen, Uwe ^b   Buelow, Roland ^c   Jozkowicz, Alicja ^d   Dulak, Jozef ^d   Volk, Hans Dieter ^a   Kotsch, Katja ^a,d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MiItenyi Biotec GmbH   (Germany)

^c Therapeutic Human Polyclonals Inc   (United States)

^d JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

HEME OXYGENASE 1; PROTOPORPHYRIN COBALT; STAT3 PROTEIN; GROWTH INHIBITOR; LIPOPOLYSACCHARIDE; PROTOPORPHYRIN; STAT3 PROTEIN, MOUSE;

ARTICLE; CELL FUNCTION; CELL MATURATION; DENDRITIC CELL; ENZYME ACTIVITY; GENE ACTIVATION; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; COCULTURE; CYTOLOGY; DNA MICROARRAY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENETICS; IMMUNOLOGY; MALE; METABOLISM; MOUSE; MOUSE MUTANT; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; GENE EXPRESSION PROFILING; GROWTH INHIBITORS; HEME OXYGENASE-1; LIPOPOLYSACCHARIDES; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; PROTOPORPHYRINS; STAT3 TRANSCRIPTION FACTOR;

EID: 50949120932     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.12.7919     Document Type: Article

References (52)

1. Fossiez, F., O. Djossou, P. Chomarat, L. Flores-Romo, S. Ait-Yahia, C Maat, J. J. Pin, P. Garrone, E. Garcia, S. Saeland, et al. 1996. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183: 2593-2603.
2. Adema, G. J., F. Hangers, R. Verstralen, E.de Vries, G. Marland, S. Menon, J. Foster, Y. Xu, P. Nooycn, T. McClanahan, et al. 1997. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 387: 713-717.
3. Morelli, A. E., and A. W. Thomson. 2003. Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction. Immunol. Rev. 196: 125-146.
4. Larsen, C. P., P. J. Morris, and J. M. Austyn. 1990. Migration of dendritic leukocytes from cardiac allografts into host spleens: a novel pathway for initiation of rejection. J. Exp. Med. 171: 307-314.
5. Saiki, T., T. Ezaki, M. Ogawa, and K. Matsuno. 2001. Trafficking of host- and donor-derived dendritic cells in rat cardiac transplantation: allosensitization in the spleen and hepatic nodes. Transplantation 71: 1806-1815.
6. Hamrah, P., S. O. Huq, Y. Liu, Q. Zhang, and M. R. Dana. 2003. Corneal immunity is mediated by heterogeneous population of antigen-presenting cells. J. Leukocyte Biol. 74: 172-178.
7. Chiang, Y. J., L. Lu, J. J. Fung, and S. Qian. 2001. Liver-derived dendritic cells induce donor-specific hyporesponsiveness: use of sponge implant as a cell transplant model. Cell Transplant. 10: 343-350.
8. +) dendritic cells: association with conversion from liver transplant tolerance to acute rejection. Transplantation 69: 2647-2657.
9. Steptoe, R. J., F. Fu, W. Li, M. L. Drakes, L. Lu, A. J. Demetris, S. Qian, H. J. McKenna, and A. W. Thomson. 1997. Augmentation of dendritic cells in murine organ donors by Flt3 ligand alters the balance between transplant tolerance and immunity. J. Immunol. 159: 5483-5491.
10. Jiang, S., O. Herrera, and R. I. Lechler. 2004. New spectrum of allorecognition pathways: implications for graft rejection and transplantation tolerance. Curr. Opin. Immunol. 16: 550-557.
11. Kappas, A., and G. S. Drummond. 1986. Control of heme metabolism with synthetic metalloporphyrins. J. Clin. Invest. 77: 335-339.
12. Chauveau, C, S. Remy, P. J. Royer, M. Hill, S. Tanguy-Royer, F. X. Hubert, L. Tesson, R. Brion, G. Beriou, M. Gregoire, et al. 2005. Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression. Blood 106: 1694-1702.
13. Listopad, J., K. Asadullah, C. Sievers, T. Ritter, C. Meisel, R. Sabat, and W. D. Docke. 2007. Heme oxygenase-1 inhibits T cell-dependent skin inflammation and differentiation and function of antigen-presenting cells. Exp. Dermatot. 16: 661-670.
14. Tenhunen, R., H. S. Marver, and R. Schmid. 1968. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc. Natl. Acad. Sci. USA 61: 748-755.
15. Ryter, S. W., J. Alam, and A. M. Choi. 2006. Heme oxygenase-I/carbon monoxide: from basic science to therapeutic applications. Physiol. Rev. 86: 583-650.
16. Tullius, S. G., M. Nieminen-Kelha, R. Buelow, A. Reutzel-Selke, P. N. Martins, J. Pratschke, U. Bachmann, M. Lehmann, D. Southard, S. Iyer, et al. 2002. Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1. Transplantation 74: 591-598.
17. Kotsch, K., M. Francuski, A. Pascher, R. Klemz, M. Seifert, J. Mittler, G. Schumacher, R. Buelow, H. D. Volk, S. G. Tullius, et al 2006. Improved long-term graft survival after HO-1 induction in brain-dead donors. Am. J. Transplant. 6: 477-486.
18. Woo, J., S. Iyer, M. C. Cornejo, N. Mori, L. Gao, I. Sipos, M. Maines, and R. Buelow. 1998. Stress protein-induced immunosuppression: inhibition of cellular immune effector functions following overexpression of haem oxygenase (HSP 32). Transpl. Immunol. 6: 84-93.
19. Gerbitz, A., P. Ewing, A. Wilke, T. Schubert, G. Eissner, B. Dietl, R. Andreesen, K. R. Cooke, and E. Holler. 2004. Induction of heme oxygenase-1 before conditioning results in improved survival and reduced graft-versus-host disease after experimental allogeneic bone marrow transplantation. Biol. Blood Marrow Transplant. 10: 461-472
20. Martins, P. N., H. Kessler, A. Jurisch, A. Reutzel-Selke, J. Kramer, A. Pascher, J. Pratschke, P. Neuhaus, H. D. Volk, and S. G. Tullius. 2005. Induction of heme oxygenase-1 in the donor reduces graft immunogenicity. Transplant. Proc. 37: 384-386.
21. Kato, H., F. Amersi, R. Buelow, J. Melinek, A. J. Coito, B. Ke, R. W. Busuttil, and J. W. Kupiec-Weglinski. 2001. Heme oxygenase-1 overexpression protects rat livers from ischemia/reperfusion injury with extended cold preservation. Am. J. Transplant. 1: 121-128.
22. Martins, P. N., A. Reutzel-Selke, A. Jurisch, C. Denecke, K. Attrot, A. Pascher, K. Kotsch, J. Pratschke, P. Neuhaus, H. D. Volk, and S. G. Tullius. 2006. Induction of carbon monoxide in donor animals prior to organ procurement reduces graft immunogenicity and inhibits chronic allografl dysfunction. Transplantation 82: 938-944.
23. Kotsch, K., P. N. Martins, R. Klemz, U. Janssen, B. Gerstmayer, A. Dernier, A. Reutzel-Selke, U. Kuckelkom, S. G. Tullius, and H. D. Volk. 2007. Heme oxygenase-1 ameliorates ischemia/reperfusion injury by targeting dendritic cell maturation and migration. Antioxid. Redox Signal. 9: 2049-2063.
24. Park, S. J., T. Nakagawa, H. Kitamura, T. Atsumi, H. Kamon, S. Sawa, D. Kamimura, N. Ueda, Y. Iwakura, K. Ishihara, et al. 2004. IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. J. Immunol. 173: 3844-3854.
25. Kapturczak, M. H., C. Wasserfall, T. Brusko, M. Campbell-Thompson, T. M. Ellis, M. A. Atkinson, and A. Agarwal. 2004. Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. Am. J. Pathol. 165: 1045-1053.
26. Kotsch, K., M. F. Mashreghi, G. Bold, P. Tretow, J. Beyer, M. Matz, J. Hoerstrup, J. Pratschke, R. Ding, M. Suthanthiran, et al. 2004. Enhanced granulysin mRNA expression in urinary sediment in early and delayed acute renal allograft rejection. Transplantation 77: 1866-1875.
27. Bosio, A., C. Knorr, U. Janssen, S. Gebel, H. J. Haussmann, and T. Muller. 2002. Kinetics of gene expression profiling in Swiss 3T3 cells exposed to aqueous extracts of cigarette smoke. Carcinogenesis 23: 741-748.
28. Weiss, S., K. Kotsch, M. Francuski, A. Reutzel-Selke, L. Mantouvalou, R. Klemz, O. Kuecuek, S. Jonas, C. Wesslau, F. Ulrich, et al. 2007. Brain death activates donor organs and is associated with a worse I/R injury after liver transplantation. Am. J. Transplant. 7: 1584-1593.
29. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176: 1693-1702.
30. Yuan, B., R. Latek, M. Hossbach, T. Tuschl, and F. Lewitter. 2004. siRNA selection server: an automated siRNA olieonucleotide prediction server. Nucleic Acids Res. 32: W130-W134.
31. Zhang, X., P. Shan, D. Jiang, P. W. Noble, N. G. Abraham, A. Kappas, and P. J. Lee. 2004. Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis. J. Biol. Chem. 279: 10677-10684.
32. Lyons, A. B., and C. R. Parish. 1994. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171: 131-137.
33. Ricchetti, G. A., L. M. Williams, and B. M. Foxwell. 2004. Heme oxygenase 1 expression induced by IL-10 requires STAT-3 and phosphoinositol-3 kinase and is inhibited by lipopolysaccharide. J. Leukocyte Biol. 76: 719-726.
34. Poss, K. D., and S. Tonegawa. 1997. Heme oxygenase 1 is required for mammalian iron reutilization. Proc. Natl. Acad. Sci. USA 94: 10919-10924.
35. Poss, K. D., and S. Tonegawa. 1997. Reduced stress defense in heme oxygenase 1-deficient cells. Proc. Natl. Acad. Sci. USA 94: 10925-10930.
36. Blaskovich, M. A., J. Sun, A. Cantor, J. Turkson, R. Jove, and S. M. Sebti. 2003. Discovery of JSI-124 (cucurbilacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res. 63: 1270-1279.
37. Kubo, M., T. Hanada, and A. Yoshimura. 2003. Suppressors of cytokine signaling and immunity. Nat. Immunol. 4: 1169-1176.
38. Brocke-Heidrich, K., B. Ge, H. Cvijie, G. Pfeifer, D. Lofller, C. Henze, T. W. McKeithan, and F. Horn. 2006. BCL3 is induced by IL-6 via Stat3 binding to intronic enhancer HS4 and represses its own transcription. Oncogene 25: 7297-7304.
39. Woolen, D. K., X. Xie, D. Bartos, R. A. Busche, G. D. Longmore, and S. S. Watowich. 2000. Cytokine signaling through Stat3 activates integrins, promotes adhesion, and induces growth arrest in the myeloid cell line 32D. J. Biol. Chem. 275: 26566-26575.
40. Nefedova, Y., P. Cheng, D. Gilkes, M. Blaskovich, A. A. Beg, S. M. Sebti, and D. I. Gabrilovich. 2005. Activation of dendritic cells via inhibition of Jak2/STAT3 signaling. J. Immunol. 175: 4338-4346.
41. Guler, M. L., J. D. Gorham, C. S. Hsieh, A. J. Mackey, R. G. Steen, W. F. Dietrich, and K. M. Murphy. 1996. Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development. Science 271: 984-987.
42. Lee, T. S., and L. Y. Chau. 2002. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat. Med. 8: 240-246.
43. Wang, T., G. Niu, M. Kortylewski, L. Burdelya, K. Shain, S. Zhang, R. Bhattacharya, D. Gabrilovich, R. Heller, D. Coppola, et al. 2004. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat. Med. 10: 48-54.
44. Corinti, S., C. Albanesi, A. la Sala, S. Pastore, and G. Girolomoni. 2001. Regulatory activity of autocrine IL-10 on dendritic cell functions. J. Immunol. 166: 4312-4318.
45. Liu, T., S. Castro, A. R. Brasier, M. Jamaluddin, R. P. Garofalo, and A. Casola. 2004. Reactive oxygen species mediate virus-induced STAT activation: role of tyrosine phosphatases. J. Biol. Chem. 279: 2461-2469.
46. Carballo, M., M. Conde, R. El Bekay, J. Martin-Nieto, M. J. Camacho, J. Monteseirin, J. Conde, F. J. Bedoya, and F. Sobrino. 1999. Oxidative stress triggers STAT3 tyrosine phosphorylation and nuclear translocation in human lymphocytes. J. Biol. Chem. 274: 17580-17586.
47. Simon, A. R., U. Rai, B. L. Fanburg, and B. H. Cochran. 1998. Activation of the JAK-STAT pathway by reactive oxygen species. Am. J. Physiol. 275: C1640-C1652.
48. Li, L., and P. E. Shaw. 2004. A STAT3 dimer formed by inter-chain disulphide bridging during oxidative stress. Biochem. Biophys. Res. Commun. 322: 1005-1011.
49. Spaethe, S. M., and D. J. Jollow. 1989. Effect of cobalt protoporphyrin on hepatic drug-metabolizing enzymes: specificity for cytochrome P-450. Biochem. Pharmacol. 38: 2027-2038.
50. Yanni, S. B., J. P. Chism, D. E. Rickert, and C. J. Serabjit-Singh. 1993. Diminished drug metabolism due to hormonal effects of cobalt mesoporphyrin on flavoproteins. Chem. Biol. Interact. 89. 73-87.
51. Maines, M. D., and G. M. Trakshel. 1992. Tin-protoporphyrin: a potent inhibitor of hemoprotein-dependent steroidogenesis in rat adrenals and testes. J. Pharmacol. Exp. Ther. 260: 909-916.
52. Zhang, X., P. Shan, G. Jiang, S. S. Zhang, L. E. Otterbein, X. Y. Fu, and P. J. Lee. 2006. Endothelial STAT3 is essential for the protective effects of HO-1 in oxidant-induced lung injury. FASEB J. 20: 2156-2158.